Product NDC: | 0641-6049 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | 4 mg/mL & nbsp; Lorazepam |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-6049 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018140 |
Marketing Category: | NDA |
Start Marketing Date: | 19800725 |
Package NDC: | 0641-6049-25 |
Package Description: | 25 VIAL in 1 CARTON (0641-6049-25) > 1 mL in 1 VIAL (0641-6049-01) |
NDC Code | 0641-6049-25 |
Proprietary Name | Lorazepam |
Package Description | 25 VIAL in 1 CARTON (0641-6049-25) > 1 mL in 1 VIAL (0641-6049-01) |
Product NDC | 0641-6049 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19800725 |
Marketing Category Name | NDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | LORAZEPAM |
Strength Number | 4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |